166 related articles for article (PubMed ID: 36859718)
1. Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy.
Oishi T; Hatakeyama S; Tabata R; Fujimori D; Fukuda M; Shinozaki T; Ishii N; Iwamura H; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Sato S; Ohyama C
Sci Rep; 2023 Mar; 13(1):3436. PubMed ID: 36859718
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
Matsumoto T; Hatakeyama S; Ookubo T; Mitsuzuka K; Narita S; Inoue T; Yamashita S; Narita T; Koie T; Kawamura S; Tochigi T; Tsuchiya N; Habuchi T; Arai Y; Ohyama C
Med Oncol; 2017 Oct; 34(12):190. PubMed ID: 29090390
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemohormonal therapy combined with radical prostatectomy and extended PLND for very high risk locally advanced prostate cancer: A retrospective comparative study.
Pan J; Chi C; Qian H; Zhu Y; Shao X; Sha J; Xu F; Wang Y; Karnes RJ; Dong B; Xue W
Urol Oncol; 2019 Dec; 37(12):991-998. PubMed ID: 31466813
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Adding Sentinel Node Biopsy to Extended Pelvic Lymph Node Dissection on Biochemical Recurrence in Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy.
Grivas N; Wit EMK; Kuusk T; KleinJan GH; Donswijk ML; van Leeuwen FWB; van der Poel HG
J Nucl Med; 2018 Feb; 59(2):204-209. PubMed ID: 28747519
[TBL] [Abstract][Full Text] [Related]
5. Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot-assisted radical prostatectomy.
Lee K; Shiota M; Takamatsu D; Ushijima M; Blas L; Okabe A; Kajioka S; Goto S; Kinoshita F; Matsumoto T; Monji K; Kashiwagi E; Inokuchi J; Oda Y; Eto M
Int J Urol; 2023 Apr; 30(4):340-346. PubMed ID: 36478611
[TBL] [Abstract][Full Text] [Related]
6. Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer.
Gandaglia G; De Lorenzis E; Novara G; Fossati N; De Groote R; Dovey Z; Suardi N; Montorsi F; Briganti A; Rocco B; Mottrie A
Eur Urol; 2017 Feb; 71(2):249-256. PubMed ID: 27209538
[TBL] [Abstract][Full Text] [Related]
7. Extended pelvic lymph node dissection in robot-assisted radical prostatectomy is an independent risk factor for major complications.
Baas DJH; de Baaij JMS; Sedelaar JPM; Hoekstra RJ; Vrijhof HJEJ; Somford DM; van Basten JA
J Robot Surg; 2024 Mar; 18(1):140. PubMed ID: 38554195
[TBL] [Abstract][Full Text] [Related]
8. Extended versus standard pelvic lymphadenectomy during robot-assisted radical prostatectomy: the role of extended template as an independent predictor of lymph node invasion with comparable morbidity burden.
Mistretta FA; Boeri L; Grasso AA; Lo Russo V; Albo G; DE Lorenzis E; Maggioni M; Palmisano F; Dell'orto P; Bosari S; Rocco B
Minerva Urol Nefrol; 2017 Oct; 69(5):475-485. PubMed ID: 28281741
[TBL] [Abstract][Full Text] [Related]
9. Standardized and simplified extended pelvic lymph node dissection during robot-assisted radical prostatectomy: the monoblock technique.
Mattei A; Di Pierro GB; Grande P; Beutler J; Danuser H
Urology; 2013 Feb; 81(2):446-50. PubMed ID: 23374827
[TBL] [Abstract][Full Text] [Related]
10. The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy.
Sebben M; Tafuri A; Shakir A; Pirozzi M; Processali T; Rizzetto R; Amigoni N; Tiso L; De Michele M; Panunzio A; Cerrato C; Brunelli M; Migliorini F; Novella G; De Marco V; Siracusano S; Artibani W; Porcaro AB
World J Urol; 2020 Nov; 38(11):2799-2809. PubMed ID: 31980875
[TBL] [Abstract][Full Text] [Related]
11. Extended pelvic lymph node dissection during robotic prostatectomy: antegrade versus retrograde technique.
Albo G; Gallioli A; Ripa F; De Lorenzis E; Boeri L; Bebi C; Rocchini L; Longo F; Zanetti SP; Turetti M; Piccoli M; Montanari E
BMC Urol; 2024 Mar; 24(1):64. PubMed ID: 38515053
[TBL] [Abstract][Full Text] [Related]
12. Extended robot-assisted laparoscopic prostatectomy and extended pelvic lymph node dissection as a monotherapy in patients with very high-risk prostate cancer Patients.
Miura N; Sugihara N; Funaki K; Kakuda T; Koyama K; Watanabe R; Sawada Y; Noda T; Nishimura K; Fukumoto T; Miyauchi Y; Kikugawa T; Saika T
Cancer Med; 2021 Nov; 10(22):7968-7976. PubMed ID: 34562303
[TBL] [Abstract][Full Text] [Related]
13. Extended pelvic lymph node dissection during radical prostatectomy: comparison between initial robotic experience of a high-volume open surgeon and his contemporary open series.
Roscigno M; La Croce G; Naspro R; Nicolai M; Manica M; Scarcello M; Chinaglia D; Da Pozzo LF
Minerva Urol Nefrol; 2019 Dec; 71(6):597-604. PubMed ID: 31144491
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.
Qian H; Chi C; Tricard T; Zhu Y; Dong L; Wang Y; Sha J; Wang J; Ma Z; Wang Y; Liu J; Dong B; Pan J; Xue W
J Urol; 2024 May; 211(5):648-655. PubMed ID: 38591703
[TBL] [Abstract][Full Text] [Related]
15. Radical Prostatectomy With and Without Neoadjuvant Chemohormonal Pretreatment for High-Risk Localized Prostate Cancer: A Comparative Propensity Score Matched Analysis.
Narita S; Nara T; Kanda S; Numakura K; Saito M; Inoue T; Satoh S; Nanjo H; Tsuchiya N; Mitsuzuka K; Koie T; Kawamura S; Ohyama C; Tochigi T; Arai Y; Habuchi T
Clin Genitourin Cancer; 2019 Feb; 17(1):e113-e122. PubMed ID: 30391137
[TBL] [Abstract][Full Text] [Related]
16. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial.
Lestingi JFP; Guglielmetti GB; Trinh QD; Coelho RF; Pontes J; Bastos DA; Cordeiro MD; Sarkis AS; Faraj SF; Mitre AI; Srougi M; Nahas WC
Eur Urol; 2021 May; 79(5):595-604. PubMed ID: 33293077
[TBL] [Abstract][Full Text] [Related]
17. Advanced age is an independent prognostic factor of disease progression in high-risk prostate cancer: results in 180 patients treated with robot-assisted radical prostatectomy and extended pelvic lymph node dissection in a tertiary referral center.
Porcaro AB; Bianchi A; Gallina S; Panunzio A; Serafin E; Mazzucato G; Orlando R; Montanaro F; Patuzzo GM; Baielli A; Artoni F; Ditonno F; Vidiri S; D'Aietti D; Migliorini F; Rizzetto R; Veccia A; Gozzo A; Brunelli M; Tafuri A; Cerruto MA; Antonelli A
Aging Clin Exp Res; 2023 Sep; 35(9):1881-1889. PubMed ID: 37337076
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.
Fujita N; Koie T; Hashimoto Y; Narita T; Tobisawa Y; Tanaka T; Noro D; Oikawa M; Hagiwara K; Yoneyama T; Imai A; Yamamoto H; Hatakeyama S; Yoneyama T; Ohyama C
Int Urol Nephrol; 2018 Nov; 50(11):1999-2005. PubMed ID: 30229466
[TBL] [Abstract][Full Text] [Related]
19. Extended pelvic lymphadenectomy and various radical prostatectomy techniques: is pelvic drainage necessary?
Danuser H; Di Pierro GB; Stucki P; Mattei A
BJU Int; 2013 May; 111(6):963-9. PubMed ID: 23356829
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Salvage Robot-assisted Radical Prostatectomy After Focal Ablation for Prostate Cancer in Comparison to Primary Robot-assisted Radical Prostatectomy: A Matched Analysis.
Bhat KRS; Covas Moschovas M; Sandri M; Noel J; Reddy S; Perera R; Rogers T; Roof S; Patel VR
Eur Urol Focus; 2022 Sep; 8(5):1192-1197. PubMed ID: 34736871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
